|
BREAST CANCER
HER2+ |
|
Setting |
Trial |
Status |
Trial |
|
1st Line *
* |
TORI B-03
Herceptin-Avastin (AVF2473) |
Open |
|
| TORI B-04 Faslodex-Herceptin - (ER/PR+) |
Open |
|
|
HER2- |
|
1st Line * |
BCIRG 010: Chemo +
AMG706 or Avastin or Placebo |
Open |
|
|
1st Line * |
GNE AVF 3694g Ribbon 1
Avastin+ Chemo |
Open |
|
|
2nd line * |
GNE AVF 3693g Ribbon 2 Avastin + Single agent Chemo - previous treatment |
Open |
|
|
|
|
COLON/GI CANCER |
|
1st Line |
Roche: Xelox
q3w + Avastin versus Xelox q2wk + Avastin |
Open |
OCOG |
|
|
|
LUNG CANCER |
|
1st-Line * |
OSI-774-203:
Tarceva + chemo |
Open |
TORI |
|
GNE AVF3671g
ATLAS: Avastin +/- Tarceva
|
Open |
TORI |
|
2nd Line |
AstraZeneca:
ZACTIMA- (ZD6474-032) + Taxotere +/- ZD6474 |
Open |
Suburban |
|
3rd Line |
Perifosine 201
|
Open |
OCOG |
|
|
|
PROSTATE / RENAL CANCER |
|
2nd Line * |
BMSCA183001: Gemzar
+/- Vinflunine/Platinum failure for TCC |
Pending |
TORI |
|
|
|
|
|
|
|
HEMATOLOGIC
|
|
NHL * |
Lilly JCBJ: Hi Risk
Diffuse Large B-Cell Lymphoma (Maintenance after complete response with
rchop) |
June 06 |
TORI |
| JNJ LYM 3001 - Velcade +/- Rituxan - relapsed/refractory B-cell |
Pending |
TORI |
|
CML Adjuvant |
Novartis STI571-2301 - Gleevec 400 vs 800 or AMN107 |
Pending |
TORI |
|
Registry |
Genentech
U2963n- Lymphoma Registry |
Open |
Suburban |
|
Multiple Myeloma-1st
line |
Tibotec D00423006 - Thal/Dex vs. Doxil Thal/Dex ( newly diagnosed) |
Open |
Suburban |
|
|
|
OTHER STUDIES
|
|
Melanoma - 1st Line * |
Pfizer
367-1009 -CTLA4-Ticilimumab + dacarbaxine or Temozolomide |
Open |
TORI |
|
Sarcomas |
Perifiosine
209- previous treatment allowed |
Open |
OCOG |
|
Nausea /Vomiting |
GSK102549: Phase III study for cancer induced nausea and vomiting |
Open |
Suburban |
|
All Solid Tumors |
Perifosine 211 - chemo + perifosine |
Open |
OCOG |
|
All Solid Tumors |
Perifosine
207- all solid tumors salvage |
Open |
OCOG |
|
GIST |
Registry-
Gastrointestinal Stromal Tumors registry |
Open |
OCOG |
|
|
|
HER 2 + OR HER 2-
|
|
Metastatic |
Novartis: CZOL446e2352
- ZOMETA in Metastatic Breast Cancer |
Open |
Suburban |
|
|
